Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (701-710 of 808) with videos related to

Pageof 81
Sort By:
Science (New York, N.Y.)|March 8, 2008
Oncogenic CARD11 mutations in human diffuse large B cell lymphomaGeorg Lenz, R Eric Davis, Vu N Ngo, et al.
British Journal of Haematology|January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysisPaolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study AssociationRobert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
Leukemia|July 9, 2016
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphomaA Bouska, W Zhang, Q Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Blood|October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma populationWaleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
European Heart Journal|November 9, 2025
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trialJean M Connors, Finn Gustafsson, Nir Uriel, et al.
Blood Advances|October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphologyLauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Pageof 81

Showing results (701-710 of 808) with videos related to

Sort By:
Pageof 81
Science (New York, N.Y.)|March 8, 2008
Oncogenic CARD11 mutations in human diffuse large B cell lymphomaGeorg Lenz, R Eric Davis, Vu N Ngo, et al.
British Journal of Haematology|January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysisPaolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study AssociationRobert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
Leukemia|July 9, 2016
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphomaA Bouska, W Zhang, Q Gong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Blood|October 27, 2022
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma populationWaleed Alduaij, Brett Collinge, Susana Ben-Neriah, et al.
European Heart Journal|November 9, 2025
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trialJean M Connors, Finn Gustafsson, Nir Uriel, et al.
Blood Advances|October 24, 2018
High-resolution architecture and partner genes of <i>MYC</i> rearrangements in lymphoma with DLBCL morphologyLauren C Chong, Susana Ben-Neriah, Graham W Slack, et al.
International Journal of Cancer|June 12, 2013
Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological featuresAnna Enjuanes, Robert Albero, Guillem Clot, et al.
Pageof 81